Table 3.
Survival estimates in ten-year intervals for the overall cohort and each histological subtype.
Histological Subtype | Time Interval (years) | Survival Probability | 95% CI |
---|---|---|---|
Overall | 10 | 79% | 74–85% |
20 | 63% | 55–71% | |
30 | 60% | 50–68% | |
40 | 31% | 18–46% | |
Mucoepidermoid | 10 | 84% | 63–94% |
20 | 62% | 32–81% | |
30 | 62% | 32–81% | |
Neuroendocrine | 10 | 89% | 82–94% |
20 | 71% | 59–80% | |
30 | 67% | 55–77% | |
Squamous | 10 | NR | |
20 | NR | ||
30 | NR | ||
Adenocarcinoma | 10 | 88% | 66–96% |
20 | 58% | 9–89% | |
30 | 58% | 9–89% | |
Blastoma | 10 | 62% | 45–75% |
20 | 41% | 10–71% | |
30 | NR | ||
Sarcoma | 10 | 77% | 56–89% |
20 | 77% | 56–89% | |
30 | 77% | 56–89% |
CI, confidence interval; NR = no patients under observation at this time.